Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Relating micromechanical properties and mineral densities in severely suppressed bone turnover patients, osteoporotic patients, and normal subjects.

Tjhia CK, Stover SM, Rao DS, Odvina CV, Fyhrie DP.

Bone. 2012 Jul;51(1):114-22. doi: 10.1016/j.bone.2012.04.010. Epub 2012 Apr 25.

2.

Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects.

Tjhia CK, Odvina CV, Rao DS, Stover SM, Wang X, Fyhrie DP.

Bone. 2011 Dec;49(6):1279-89. doi: 10.1016/j.bone.2011.09.042. Epub 2011 Sep 18.

3.

Defining hypercalciuria in nephrolithiasis.

Pak CY, Sakhaee K, Moe OW, Poindexter J, Adams-Huet B, Pearle MS, Zerwekh JE, Preminger GM, Wills MR, Breslau NA, Bartter FC, Brater DC, Heller HJ, Odvina CV, Wabner CL, Fordtran JS, Oh M, Garg A, Harvey JA, Alpern RJ, Snyder WH, Peters PC.

Kidney Int. 2011 Oct;80(7):777-82. doi: 10.1038/ki.2011.227. Epub 2011 Jul 20. Review.

4.

Unusual mid-shaft fractures during long-term bisphosphonate therapy.

Odvina CV, Levy S, Rao S, Zerwekh JE, Rao DS.

Clin Endocrinol (Oxf). 2010 Feb;72(2):161-8. doi: 10.1111/j.1365-2265.2009.03581.x. Epub 2009 Mar 19.

PMID:
19302584
5.

Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis.

Odvina CV, Poindexter JR, Peterson RD, Zerwekh JE, Pak CY.

Urol Res. 2008 Oct;36(5):233-9. doi: 10.1007/s00240-008-0146-4. Epub 2008 Jul 17.

PMID:
18633606
6.

Comparative value of orange juice versus lemonade in reducing stone-forming risk.

Odvina CV.

Clin J Am Soc Nephrol. 2006 Nov;1(6):1269-74. Epub 2006 Aug 30.

7.

Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.

Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.

J Urol. 2007 Jun;177(6):2179-84.

PMID:
17509313
8.

Biochemical characterization of primary hyperparathyroidism with and without kidney stones.

Odvina CV, Sakhaee K, Heller HJ, Peterson RD, Poindexter JR, Padalino PK, Pak CY.

Urol Res. 2007 Jun;35(3):123-8. Epub 2007 May 3.

PMID:
17476495
9.

Osteoporosis: how should it be treated?

Odvina CV.

J Investig Med. 2006 Apr;54(3):114-22. doi: 10.2310/6650.2006.05037. Review.

PMID:
16948394
10.

Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.

Odvina CV, Mason RP, Pak CY.

Am J Ther. 2006 Mar-Apr;13(2):101-8.

PMID:
16645424
11.

Response to Taylor and Curhan.

Pearle MS, Odvina CV, Sakhaee K, Pak CY.

Kidney Int. 2006 Apr;69(8):1482. No abstract available.

12.

Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature.

Maalouf NM, Heller HJ, Odvina CV, Kim PJ, Sakhaee K.

Endocr Pract. 2006 Jan-Feb;12(1):48-53. Review.

PMID:
16524863
13.

Effect of dietary modification on urinary stone risk factors.

Pak CY, Odvina CV, Pearle MS, Sakhaee K, Peterson RD, Poindexter JR, Brinkley LJ.

Kidney Int. 2005 Nov;68(5):2264-73.

14.

Reduction in normalized bone elasticity following long-term bisphosphonate treatment as measured by ultrasound critical angle reflectometry.

Richer E, Lewis MA, Odvina CV, Vazquez MA, Smith BJ, Peterson RD, Poindexter JR, Antich PP, Pak CY.

Osteoporos Int. 2005 Nov;16(11):1384-92. Epub 2005 Feb 22.

PMID:
15726294
15.

Severely suppressed bone turnover: a potential complication of alendronate therapy.

Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY.

J Clin Endocrinol Metab. 2005 Mar;90(3):1294-301. Epub 2004 Dec 14.

PMID:
15598694
16.

A case of chromosome 22q11 deletion syndrome diagnosed in a 32-year-old man with hypoparathyroidism.

Maalouf NM, Sakhaee K, Odvina CV.

J Clin Endocrinol Metab. 2004 Oct;89(10):4817-20.

PMID:
15472168
17.

Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.

Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.

J Urol. 2003 Feb;169(2):465-9.

PMID:
12544288
18.
19.

Effect of heavy alcohol intake in the absence of liver disease on bone mass in black and white men.

Odvina CV, Safi I, Wojtowicz CH, Barengolts EI, Lathon P, Skapars A, Desai PN, Kukreja SC.

J Clin Endocrinol Metab. 1995 Aug;80(8):2499-503.

PMID:
7629250
20.

Efficacy of long-term fluoride and calcium therapy in correcting the deficit of spinal bone density in osteoporosis.

Farley SM, Libanati CR, Odvina CV, Smith L, Eliel L, Wakley GK, Kilcoyne R, Schulz EE, Baylink DJ.

J Clin Epidemiol. 1989;42(11):1067-74.

PMID:
2809662
21.

Relationship between trabecular vertebral body density and fractures: a quantitative definition of spinal osteoporosis.

Odvina CV, Wergedal JE, Libanati CR, Schulz EE, Baylink DJ.

Metabolism. 1988 Mar;37(3):221-8.

PMID:
3343930

Supplemental Content

Loading ...
Support Center